Wooldridge James
Insider CIK 1710641 · AGLE Chief Medical Officer · CMPI Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CMPI Checkmate Pharmaceuticals, | D To issuer deriv | 2022-05-31 | 2022-05-31 | 54,600 | — | $0 | 0 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | D To issuer deriv | 2022-05-31 | 2022-05-31 | 101,180 | — | $0 | 0 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | D To issuer deriv | 2022-05-31 | 2022-05-31 | 27,300 | — | $0 | 0 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | D To issuer deriv | 2022-05-31 | 2022-05-31 | 150,818 | — | $0 | 0 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | D To issuer deriv | 2022-05-31 | 2022-05-31 | 95,916 | — | $0 | 0 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | A Award deriv | 2022-01-27 | 2022-01-31 | 101,180 | — | $0 | 101,180 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | A Award deriv | 2021-08-04 | 2021-08-06 | 27,300 | — | $0 | 27,300 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | A Award deriv | 2021-03-04 | 2022-04-28 | 54,600 | — | $0 | 54,600 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | A Award deriv | 2020-08-06 | 2020-08-10 | 150,818 | — | $0 | 150,818 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2019-02-28 | 2019-03-01 | 50,200 | — | $0 | 50,200 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2018-02-20 | 2018-02-22 | 45,000 | — | $0 | 45,000 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2017-08-22 | 2017-08-24 | 165,000 | — | $0 | 165,000 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2017-08-22 | 2017-08-24 | 10,000 | — | $0 | 10,000 | SEC↗ |